INIS
heparin
100%
bypasses
100%
patients
41%
thrombin
41%
comparative evaluations
25%
filters
25%
values
25%
administration
16%
morbidity
16%
protamines
16%
blood
16%
operation
16%
enzymes
16%
scanning electron microscopy
8%
surgery
8%
clinical trials
8%
surfaces
8%
risks
8%
proteins
8%
deposition
8%
units
8%
populations
8%
stimulation
8%
length
8%
losses
8%
mortality
8%
plasma
8%
doses
8%
valves
8%
granulocytes
8%
coronaries
8%
arteries
8%
oxygen
8%
ventilation
8%
control systems
8%
removal
8%
transfusions
8%
Medicine and Dentistry
Heparin
100%
Cardiopulmonary Bypass
75%
Thrombin
41%
Thrombocyte Activation
25%
Biocompatibility
25%
Morbidity
16%
Surgery
16%
Enzyme Linked Immunosorbent Assay
16%
Bleeding
16%
Protamine
16%
Leukocyte Activation
16%
PADGEM Protein
16%
Patient
16%
Inpatient
16%
Oxygen
8%
Scanning Electron Microscopy
8%
Patient Population
8%
Platelet
8%
Stimulation
8%
Qualitative Analysis
8%
Blood Proteins
8%
Heart Surgery
8%
Antithrombotic
8%
Flow Cytometry
8%
Coronary Artery Bypass Graft
8%
Extubation
8%
Granulocyte
8%
Bypass
8%
Thrombocytopoiesis
8%
Blood Transfusion
8%
Postoperative Hemorrhage
8%
Antithrombin III
8%
Mortality
8%
4 Chloro 3',6' Dimethyl 2,2' Iminodibenzoic Acid
8%
Extracorporeal Circulation
8%
Quantitative Analysis
8%
Clinical Trial
8%
Marker
8%
Intensive Care Unit
8%
Syndrome
8%